Related Experiment Videos
Some possible gynaecological indications for peripheral antidopamine therapy
1Second Department of Obstetric and Gynaecology, Municipal János Hospital-Outpatient Clinic.
Therapia Hungarica (English Edition)
|January 1, 1992
Summary
Domperidone effectively managed various gynecological symptoms, including nausea, vomiting, and hot flashes, with significant success in 67.1% of patients. This dopamine receptor blocker also showed promise in migraine prevention and treatment.
Area of Science:
- Pharmacology
- Gastroenterology
- Gynecology
Background:
- Domperidone is a dopamine receptor antagonist.
- Its gastrokinetic and antiemetic properties are well-established.
- Its efficacy in gynecological patients with diverse symptoms requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of domperidone in managing a range of gynecological symptoms.
- To assess domperidone's utility in controlling dyspepsia, nausea, vomiting, climacteric flushes, and migraine prevention.
Main Methods:
- A study involving 73 gynecological patients.
- Domperidone (Motilium) administered for various indications.
- Assessment of treatment response based on symptom control.
Main Results:
- Successful symptom control in 67.1% of cases.
- Partial response observed in 19.2% of patients.
- No response in 13.7% of the study population.
Conclusions:
- Domperidone demonstrated significant efficacy in treating dyspeptic symptoms, nausea-vomiting, and climacteric flushes in gynecological patients.
- The drug is valuable for migraine prevention and managing menopausal symptoms.
- Domperidone can be used as a monotherapy or adjuvant therapy for these conditions.